Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies
Turner, Leigh, Martinez, Juan Ramon, Najjar, Shemms, Arachchilage, Thevin Rajapaksha, Sahrai, Victoria, Wang, Jia Chieng
Published in Regenerative medicine (01.10.2023)
Published in Regenerative medicine (01.10.2023)
Get full text
Journal Article
US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era
Turner, Leigh, Wang, Jia Chieng, Martinez, Juan Ramon, Najjar, Shemms, Rajapaksha Arachchilage, Thevin, Sahrai, Victoria
Published in Cytotherapy (Oxford, England) (01.04.2024)
Published in Cytotherapy (Oxford, England) (01.04.2024)
Get full text
Journal Article
Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims
Turner, Leigh, Martinez, Juan Ramon, Najjar, Shemms, Rajapaksha Arachchilage, Thevin, Wang, Jia Chieng
Published in Stem cell reports (14.11.2023)
Published in Stem cell reports (14.11.2023)
Get full text
Journal Article